Patents Assigned to Orthopeutics, L.P.
-
Patent number: 10980771Abstract: A protein crosslinker delivery device includes a body and a protein crosslinker held in a synthetic or natural biodegradable polymer. The body, a coating on the body, or an attachment to the body can contain the protein crosslinker holding biodegradable polymer. The release rate of the crosslinker and total amount of crosslinker released can be controlled by varying the concentration of the crosslinker and by varying the composition and structural characteristics of the degradable polymer. Surface eroding, bulk eroding and naturally occurring biodegradable polymers can be used in conjunction with a variety of nontoxic or minimally-toxic protein crosslinking agents. The devices can be used to treat mechanically damaged, deformed, and nutritionally deficient connective or soft tissues such as the knee meniscus, the spinal disc, the cornea, ligaments and tendons, the soft palate, and skin.Type: GrantFiled: October 26, 2018Date of Patent: April 20, 2021Assignee: Orthopeutics, L.P.Inventors: Pawel Slusarewicz, David A. Puleo, Thomas Paul Hedman, Sharath C. Sundararaj
-
Patent number: 10278947Abstract: A protein crosslinker delivery device includes a body and a protein crosslinker held in a synthetic or natural biodegradable polymer. The body, a coating on the body, or an attachment to the body can contain the protein crosslinker holding biodegradable polymer. The release rate of the crosslinker and total amount of crosslinker released can be controlled by varying the concentration of the crosslinker and by varying the composition and structural characteristics of the degradable polymer. Surface eroding, bulk eroding and naturally occurring biodegradable polymers can be used in conjunction with a variety of nontoxic or minimally-toxic protein crosslinking agents. The devices can be used to treat mechanically damaged, deformed, and nutritionally deficient connective or soft tissues such as the knee meniscus, the spinal disc, the cornea, ligaments and tendons, the soft palate, and skin.Type: GrantFiled: February 12, 2014Date of Patent: May 7, 2019Assignee: ORTHOPEUTICS, L.P.Inventors: Pawel Slusarewicz, David A. Puleo, Thomas Paul Hedman, Sharath C. Sundararaj
-
Patent number: 9918870Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.Type: GrantFiled: September 29, 2015Date of Patent: March 20, 2018Assignee: Orthopeutics, L.P.Inventors: Thomas P. Hedman, Pawel Slusarewicz
-
Patent number: 9492592Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.Type: GrantFiled: April 13, 2015Date of Patent: November 15, 2016Assignee: Orthopeutics, L. P.Inventors: Thomas P. Hedman, Pawel Slusarewicz
-
Patent number: 9192507Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.Type: GrantFiled: June 28, 2011Date of Patent: November 24, 2015Assignee: Orthopeutics, L.P.Inventors: Thomas P. Hedman, Pawel Slusarewicz
-
Patent number: 9101602Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. The crosslinking reagent includes a crosslinking agent such as genipin and/or proanthrocyanidin. Further, the crosslinking reagent may include a crosslinking agent in a carrier medium. The collagenous tissue to be contacted with the crosslinking reagent is preferably a portion of an intervertebral disc or articular cartilage. The contact between the tissue and the crosslinking reagent is effected by injections directly into the select tissue using a needle. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system such as a gel or ointment, or a treated membrane or patch directly into or onto the target tissue. Contact may also be effected by, for instance, soaking.Type: GrantFiled: December 13, 2010Date of Patent: August 11, 2015Assignee: Orthopeutics L.P.Inventor: Thomas P. Hedman
-
Publication number: 20150217025Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.Type: ApplicationFiled: April 13, 2015Publication date: August 6, 2015Applicant: Orthopeutics, L.P.Inventors: Thomas P. Hedman, Paul Slusarewicz
-
Patent number: 9084772Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. The crosslinking reagent includes a crosslinking agent such as genipin and/or proanthrocyanidin. Further, the crosslinking reagent may include a crosslinking agent in a carrier medium. The collagenous tissue to be contacted with the crosslinking reagent is preferably a portion of an intervertebral disc or articular cartilage. The contact between the tissue and the crosslinking reagent is effected by injections directly into the select tissue using a needle. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system such as a gel or ointment, or a treated membrane or patch directly into or onto the target tissue. Contact may also be effected by, for instance, soaking.Type: GrantFiled: August 29, 2002Date of Patent: July 21, 2015Assignee: Orthopeutics L.P.Inventor: Thomas P. Hedman
-
Publication number: 20140161844Abstract: A protein crosslinker delivery device includes a body and a protein crosslinker held in a synthetic or natural biodegradable polymer. The body, a coating on the body, or an attachment to the body can contain the protein crosslinker holding biodegradable polymer. The release rate of the crosslinker and total amount of crosslinker released can be controlled by varying the concentration of the crosslinker and by varying the composition and structural characteristics of the degradable polymer. Surface eroding, bulk eroding and naturally occurring biodegradable polymers can be used in conjunction with a variety of nontoxic or minimally-toxic protein crosslinking agents. The devices can be used to treat mechanically damaged, deformed, and nutritionally deficient connective or soft tissues such as the knee meniscus, the spinal disc, the cornea, ligaments and tendons, the soft palate, and skin.Type: ApplicationFiled: February 12, 2014Publication date: June 12, 2014Applicant: Orthopeutics, L.P.Inventors: Pawel Slusarewicz, David A. Puleo, Thomas Paul Hedman, Sharath C. Sundararaj
-
Patent number: 8450276Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the bending stiffness of scoliotic spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the scoliotic curve. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the target tissue.Type: GrantFiled: June 16, 2010Date of Patent: May 28, 2013Assignee: Orthopeutics L.P.Inventor: Thomas P. Hedman
-
Publication number: 20130087155Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.Type: ApplicationFiled: June 28, 2011Publication date: April 11, 2013Applicant: ORTHOPEUTICS, L.P.Inventors: Thomas P. Hedman, Pawel Slusarewicz
-
Publication number: 20130085569Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.Type: ApplicationFiled: May 26, 2011Publication date: April 4, 2013Applicant: Orthopeutics, L.P.Inventors: Thomas P. Hedman, Paul Slusarewicz
-
Patent number: 8211938Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.Type: GrantFiled: March 2, 2010Date of Patent: July 3, 2012Assignee: Orthopeutics, L.P.Inventor: Thomas P. Hedman
-
Patent number: 8153600Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic and other progressively deforming spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the elasticity and bending stiffness of progressively deforming spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the potential or progressing deformity curve. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the target tissue.Type: GrantFiled: February 2, 2006Date of Patent: April 10, 2012Assignee: Orthopeutics, L.P.Inventor: Thomas P. Hedman
-
Patent number: 8119599Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.Type: GrantFiled: October 17, 2007Date of Patent: February 21, 2012Assignee: Orthopeutics, L.P.Inventors: Thomas P. Hedman, Paul Slusarewicz
-
Patent number: 8022101Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.Type: GrantFiled: February 28, 2007Date of Patent: September 20, 2011Assignee: Orthopeutics, L.P.Inventor: Thomas P. Hedman